Evaluation and Management of Neuroendocrine Tumors of the Pancreas - 27/06/19
Résumé |
Pancreatic neuroendocrine tumors are a diverse group of neoplasms with a generally favorable prognosis. Although they exhibit indolent growth, metastases are seen in roughly 60% of patients. Pancreatic neuroendocrine tumors may produce a wide variety of hormones, which are associated with dramatic symptoms, but the majority are nonfunctional. The diagnosis and treatment of these tumors is a multidisciplinary effort, and management guidelines continue to evolve. This review provides a concise summary of the presentation, diagnosis, surgical management, and systemic treatment of pancreatic neuroendocrine tumors.
Le texte complet de cet article est disponible en PDF.Keywords : Pancreas, Neuroendocrine tumor, PNET, Surgery
Plan
Disclosure Statement: The authors have no conflicts of interest to disclose. |
|
This work was supported by the T32 grant CA148062-0 (A.T. Scott) and SPORE grant P50 CA174521-01 (J.R. Howe). |
Vol 99 - N° 4
P. 793-814 - août 2019 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?